Phase 3 Reflux Esophagitis (RE) Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Clinical Trial of Anaprazole for Treating Reflux Esophagitis.
Reflux Esophagitis (RE)
Xuanzhu Biopharmaceutical Co., Ltd.500 enrolled1 locationNCT07010107
Recruiting
Phase 3
A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis
Reflux Esophagitis (RE)
Livzon Pharmaceutical Group Inc.356 enrolled1 locationNCT06850480